- Home
- EDSA vs VNCE Comparison
EDSA vs VNCE Comparison
Compare EDSA & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- VNCE
- Stock Information
- Founded
- EDSA 2015
- VNCE 2002
- Country
- EDSA Canada
- VNCE United States
- Employees
- EDSA N/A
- VNCE N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- VNCE Clothing/Shoe/Accessory Stores
- Sector
- EDSA Health Care
- VNCE Consumer Discretionary
- Exchange
- EDSA Nasdaq
- VNCE Nasdaq
- Market Cap
- EDSA 17.5M
- VNCE 20.2M
- IPO Year
- EDSA N/A
- VNCE 2013
- Fundamental
- Price
- EDSA $2.72
- VNCE N/A
- Analyst Decision
- EDSA Strong Buy
- VNCE Strong Buy
- Analyst Count
- EDSA 2
- VNCE 4
- Target Price
- EDSA $13.00
- VNCE $4.63
- AVG Volume (30 Days)
- EDSA 121.9K
- VNCE 4.9M
- Earning Date
- EDSA 08-08-2025
- VNCE 09-10-2025
- Dividend Yield
- EDSA N/A
- VNCE N/A
- EPS Growth
- EDSA N/A
- VNCE N/A
- EPS
- EDSA N/A
- VNCE N/A
- Revenue
- EDSA N/A
- VNCE $291,286,000.00
- Revenue This Year
- EDSA N/A
- VNCE $1.48
- Revenue Next Year
- EDSA N/A
- VNCE $4.92
- P/E Ratio
- EDSA N/A
- VNCE N/A
- Revenue Growth
- EDSA N/A
- VNCE N/A
- 52 Week Low
- EDSA $1.55
- VNCE $1.02
- 52 Week High
- EDSA $4.49
- VNCE $6.89
- Technical
- Relative Strength Index (RSI)
- EDSA 62.87
- VNCE 59.70
- Support Level
- EDSA $2.47
- VNCE $2.83
- Resistance Level
- EDSA $2.82
- VNCE $3.39
- Average True Range (ATR)
- EDSA 0.18
- VNCE 0.37
- MACD
- EDSA 0.03
- VNCE -0.05
- Stochastic Oscillator
- EDSA 85.46
- VNCE 52.33
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About VNCE Vince Holding Corp.
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.